Announcements Trials

Browse Landscape

Phase

Phase NA 2 Phase 2 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Prostatic Neoplasms 12 Breast Neoplasms 8 Vitamin D Deficiency 4 Myelodysplastic Syndromes 4 Leukemia, Myeloid, Acute 3 Leukemia 3 Rectal Neoplasms 2 Polycystic Ovary Syndrome 2 Ovarian Neoplasms 2 Myeloproliferative Disorders 2 Myelodysplastic-Myeloproliferative Diseases 2 Male Urogenital Diseases 2 Colorectal Neoplasms 2 Colonic Neoplasms 2 Warts 1 Triple Negative Breast Neoplasms 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Pancreatic Neoplasms 1 Pain 1 Osteoporosis 1 Obesity 1 Neurofibromatosis 1 1 Neuralgia 1 Neoplasms 1 Lymphoma, Non-Hodgkin 1 Lymphoma 1 Leukemia, Myelomonocytic, Chronic 1 Leukemia, Myelomonocytic, Acute 1 Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 1 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 1

Interventions

resiquimod 6 lactic acid, salicylic acid drug combination 1 human papillomavirus vaccine, L1 type 16, 18 1 VP-102 1 Sugars 1 PRA1 protein, Candida albicans 1 Nitric Oxide 1 Maltose 1 Interferon-alpha 1 Cidofovir 1 Cholecalciferol 1 Cantharidin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Warts × Cholecalciferol × Clear all

NCT04278573 2024-04-30

Intralesional Vitamin D Injection for Treatment of Common Warts

Mayo Clinic

Phase 2 Completed

77 enrolled 10 charts

Warts

Data powered by HemOnc (CC BY 4.0) Colophon ⚡